SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Dividend Updates
The Board of Directors of the Company recommended the Dividend for the FY 2023-2429-05-2024
29-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Financial Results For The Fourth Quarter And FY Ended 31St March, 2024
Financial Results for the Fourth quarter and FY ended 31st March, 202429-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting29-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor's Conference Call scheduled to be held on Friday, 31st May, 2024 at 11:00 AM IST.27-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Intimation Of Board Meeting
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company scheduled to be held on Wednesday, 29th May, 2024 at the Registered Office of the Company22-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Report of the Monitoring Agency with respect to utilization of proceeds of the Preferential issue of warrants of the Company.14-05-2024
SMS PHARMACEUTICALS LTD. - 532815 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySMS PHARMACEUTICALS LTD. 2CIN NO.L24239TG1987PLC008066 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 279.04 4Highest Credit Rating during the previous FY A- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Thirumalesh Tumma Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: T Lakshmi Narayana Designation: Chief Financial Officer EmailId: [email protected] Date: 30/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.30-04-2024
SMS PHARMACEUTICALS LTD. - 532815 - Compliance Certificate Under Regulation 40(9)&(10) Of SEBI (LODR) Regulations, 2015, For The Year Ended On 31St March, 2024
Compliance certificate under regulation 40(9) & (10) of SEBI (LODR) Regulations, 2015, for the year ended on 31st March, 2024.20-04-2024
SMS PHARMACEUTICALS LTD. - 532815 - Compliance Certificate Under Regulation 7(3) Of SEBI (LODR), Regulations, 2015 For The Period Ended 31St March, 2024.
Compliance certificate under Regulation 7(3) of SEBI (LODR), Regulations, 2015 for the period ended March 31, 2024.16-04-2024
SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg74(5) of SEBI(DP) Regulations, 201810-04-2024